Device type · JBP
Activated Whole Blood Clotting Time
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
JBP
Hematology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
46
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Activated Whole Blood Clotting Time
- Product code
- JBP
- Device class
- Class II
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7140
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JBP
Latest FDA decisions
K223635 · Decided Jan 4, 2023 · 30 days after receipt
Device type: Activated Whole Blood Clotting Time (JBP) · Laboratory Medicine & Pathology
Reports received
46
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
44
96% of reports
Injury reports
2
4.3% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 3 | 0 | 0 | 0 |
| Mar 24 | 2 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 11 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 3 | 0 | 1 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 2 | 0 | 0 | 0 |
| Feb 25 | 5 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 2 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 2 | 0 | 0 | 0 |
| Oct 25 | 2 | 0 | 0 | 0 |
| Nov 25 | 2 | 0 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 6 | 1 | 0 | 0 |
| Mar 26 | 12 | 1 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 4 | 0 | 0 | 0 |
| Jun 26 | 6 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 4 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 4 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect, Inadequate or Imprecise Result or Readings39
- Difficult to Open or Close1
- Manufacturing, Packaging or Shipping Problem1
1 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions32
- Atrial Fibrillation6
- Coagulation Disorder2
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0880-2026 · Started Nov 5, 2025 · Posted by FDA Dec 3, 2025
Reason given: Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.
Cause as FDA categorized it: Packaging process control
Z-0539-2026 · Started Oct 20, 2025 · Posted by FDA Nov 18, 2025
Reason given: Medtronic personnel observed trace amounts of dry blood on the external carton label and Instructions for Use (IFU) in five boxes of one lot of ACT Cartridges.
Cause as FDA categorized it: Under Investigation by firm
Z-1341-2011 · Started Dec 3, 2010 · Posted by FDA Feb 16, 2011
Reason given: Celite ACT cartridges have increased numbers of values outside the accepted allowable error.
Cause as FDA categorized it: Device Design
7 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.